
Opinion|Videos|June 17, 2024
Adverse Effect Management and the Role of Immunotherapy in NMIBC
Experts on bladder cancer discusses strategies to minimize adverse effects and the role of immunotherapy in BCG-unresponsive NMIBC treatment paradigms.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA updates in urology: December 2025
2
TRT myths, metabolic risk, and the role of the urologist
3
How sex influences the bladder cancer tumor microenvironment
4
John Michael DiBianco, MD, highlights trial of stent omission after ureteroscopy
5



















